Immunotherapy for colorectal cancer
- 1 April 1999
- journal article
- review article
- Published by Elsevier in The American Journal of Surgery
- Vol. 177 (4) , 344-348
- https://doi.org/10.1016/s0002-9610(99)00051-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Preoperative lnterleukin-2 Subcutaneous Immunotherapy May Prolong the Survival Time in Advanced Colorectal Cancer PatientsOncology, 1996
- HUMAN IMMUNE RESPONSE TO CARCINOEMBRYONIC ANTIGEN TUMOR VACCINESJournal of Immunotherapy, 1995
- Specific Immunotherapy Using a Recombinant Vaccinia Virus Expressing Human Carcinoembryonic AntigenAnnals of the New York Academy of Sciences, 1993
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Immune response to tumor antigens in a patient with colorectal cancer after immunization with anti-idiotype antibodyClinical Immunology and Immunopathology, 1992
- A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)International Journal of Cancer, 1991
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990
- Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trialBritish Journal of Surgery, 1989
- Long-Term Survival Following Levamisole or Placebo Adjuvant Treatment of Colorectal Cancer: A Western Cancer Study Group TrialOncology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987